ATE264669T1 - Stereokomplexe hydrogele - Google Patents

Stereokomplexe hydrogele

Info

Publication number
ATE264669T1
ATE264669T1 AT00906759T AT00906759T ATE264669T1 AT E264669 T1 ATE264669 T1 AT E264669T1 AT 00906759 T AT00906759 T AT 00906759T AT 00906759 T AT00906759 T AT 00906759T AT E264669 T1 ATE264669 T1 AT E264669T1
Authority
AT
Austria
Prior art keywords
interaction
hydrogels
stereocomplex
chirality
hydrogel
Prior art date
Application number
AT00906759T
Other languages
English (en)
Inventor
Wilhelmus Everhardus Hennink
Nostrum Cornelus Franciscu Van
Jong Silvia Johanna De
Original Assignee
Univ Utrecht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utrecht filed Critical Univ Utrecht
Application granted granted Critical
Publication of ATE264669T1 publication Critical patent/ATE264669T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/12—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity
    • C08L101/14—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity the macromolecular compounds being water soluble or water swellable, e.g. aqueous gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
AT00906759T 1999-02-19 2000-02-21 Stereokomplexe hydrogele ATE264669T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99200472 1999-02-19
PCT/NL2000/000108 WO2000048576A1 (en) 1999-02-19 2000-02-21 Stereocomplex hydrogels

Publications (1)

Publication Number Publication Date
ATE264669T1 true ATE264669T1 (de) 2004-05-15

Family

ID=8239899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906759T ATE264669T1 (de) 1999-02-19 2000-02-21 Stereokomplexe hydrogele

Country Status (9)

Country Link
US (2) US7776359B1 (de)
EP (1) EP1183016B1 (de)
JP (1) JP4865947B2 (de)
AT (1) ATE264669T1 (de)
AU (1) AU2831900A (de)
DE (1) DE60010072T2 (de)
DK (1) DK1183016T3 (de)
ES (1) ES2220406T3 (de)
WO (1) WO2000048576A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1409647A4 (de) 2001-04-30 2009-09-09 Yissum Res Dev Co Zusammengesetzte gerüste und verfahren unter ihrer verwendung bei der erzeugung von komplexen gewebetransplantaten
JP2006175153A (ja) * 2004-12-24 2006-07-06 Goodman Co Ltd 医療用生分解性生体吸収材料
ATE485051T1 (de) * 2003-03-04 2010-11-15 Technology Dev Company Ltd Injizierbare insulinzubereitung mit langzeitwirkung und verfahren zur dessen herstellung und verwendung
JP4459543B2 (ja) 2003-03-17 2010-04-28 株式会社メドジェル 徐放性ハイドロゲル製剤
EP1699837A1 (de) * 2003-12-04 2006-09-13 Universiteit Utrecht Stereokomplex-hydrogele mit einstellbaren abbauzeiten
EP1576952A1 (de) * 2004-03-18 2005-09-21 OctoPlus Technologies B.V. Hydrogel-Mikrosphären mit verbessertem Freisetzungsprofil
EP1595534A1 (de) 2004-05-13 2005-11-16 Universiteit Utrecht Holding B.V. Gelzusammensetzung enthaltend geladenepolymere
EP1891941A1 (de) * 2006-08-11 2008-02-27 OctoPlus Technologies B.V. Wässrige Gele enthaltend Mikrokügelchen
EP2147031B1 (de) * 2007-03-20 2011-09-14 University Of Twente Stereophotohydrogel, verfahren zur herstellung des stereophotohydrogels, polymere zur verwendung bei der herstellung eines derartigen hydrogels und pharmazeutikum, das die polymere enthält
EP2558518A1 (de) * 2010-04-14 2013-02-20 Agency For Science, Technology And Research Aus polymilchsäure und einem elastomeren pfropfcopolymer gebildete thermoplastische zusammensetzung
EP3045502B1 (de) 2010-09-14 2018-06-27 Osaka University Verfahren zur selbstanordnung eines materials und selektives haftverfahren auf basis einer molekularen erkennung
FR2966248B1 (fr) * 2010-10-18 2020-05-01 Centre National De La Recherche Scientifique (Cnrs) Procede de fonctionnalisation de surfaces pour la detection d'analytes
US8642086B2 (en) 2011-03-31 2014-02-04 International Business Machines Corporation Antimicrobial compositions, methods of preparation thereof, and uses thereof
US8709466B2 (en) 2011-03-31 2014-04-29 International Business Machines Corporation Cationic polymers for antimicrobial applications and delivery of bioactive materials
NL1039667C2 (en) * 2012-06-11 2013-12-12 Purac Biochem Bv Quantification of lactide amounts in a polymeric matrix.
US9878000B2 (en) 2012-06-20 2018-01-30 University Of Waterloo Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
WO2013188979A1 (en) * 2012-06-20 2013-12-27 Frank Gu Mucoadhesive nanoparticle delivery system
CN103816841B (zh) * 2013-12-05 2015-08-26 江南大学 一种具有等离子体手性的水凝胶的制备方法
CN104940995B (zh) * 2015-06-29 2017-04-12 哈尔滨工业大学 一种以牛血清白蛋白为基元反相微乳液制备蛋白质水凝胶微球的方法
EP3482964A1 (de) * 2017-11-13 2019-05-15 Mitsubishi HiTec Paper Europe GmbH Wärmeempfindliches aufzeichnungsmaterial auf basis von pla
CN109316632B (zh) * 2018-11-15 2021-04-20 北京大学口腔医学院 使用左旋水凝胶材料促进骨髓间充质干细胞成骨分化的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE37983T1 (de) * 1982-04-22 1988-11-15 Ici Plc Mittel mit verzoegerter freigabe.
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
US4650488A (en) * 1984-05-16 1987-03-17 Richards Medical Company Biodegradable prosthetic device
JPS6136321A (ja) * 1984-07-27 1986-02-21 Daicel Chem Ind Ltd 新規なポリマ−およびその樹脂組成物
US4788979A (en) * 1986-09-23 1988-12-06 American Cyanamid Company Bioabsorbable coating for a surgical article
US4902515A (en) 1988-04-28 1990-02-20 E. I. Dupont De Nemours And Company Polylactide compositions
US5230900A (en) * 1988-07-01 1993-07-27 The Biomembrane Institute Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells
AU3360197A (en) 1996-07-01 1998-01-21 Universiteit Utrecht Hydrolysable hydrogels for controlled release
IL122933A (en) 1998-01-14 2005-03-20 Efrat Biopolymers Ltd Polymeric carrier for delivery of a bioactive molecule
JPH11269097A (ja) * 1998-01-20 1999-10-05 Takeda Chem Ind Ltd 新規な微粒子、その製造法および用途
JP3687354B2 (ja) * 1998-06-30 2005-08-24 トヨタ自動車株式会社 ポリ乳酸ステレオコンプレックスポリマー組成物
US7049357B2 (en) * 2001-04-23 2006-05-23 The Glidden Company Odor free polylactic acid modified aqueous emulsion paints free of volatile coalescing organic solvent

Also Published As

Publication number Publication date
EP1183016B1 (de) 2004-04-21
DK1183016T3 (da) 2004-08-09
DE60010072D1 (de) 2004-05-27
DE60010072T2 (de) 2005-03-24
AU2831900A (en) 2000-09-04
JP2002537416A (ja) 2002-11-05
ES2220406T3 (es) 2004-12-16
WO2000048576A1 (en) 2000-08-24
US7776359B1 (en) 2010-08-17
EP1183016A1 (de) 2002-03-06
US20100255098A1 (en) 2010-10-07
JP4865947B2 (ja) 2012-02-01

Similar Documents

Publication Publication Date Title
DK1183016T3 (da) Stereokomplekse hydrogeler
ATE399827T1 (de) Saug- und gleitfähiges beschichtungsmittel und damit beschichtete erzeugnisse
HUP0100466A2 (hu) Biológiai úton lebomlani képes, emlékező polimerek
NO20023230D0 (no) Hydrogeler
FI955320A0 (fi) Bioaktiivisia ja/tai kohdennettuja dendriimikonjugaatteja
BR0212176A (pt) Composição de poli-alfa olefina, lubrificante, e, métodos de fabricação de uma poli-alfa olefina, e de um lubrificante
EA200000591A1 (ru) Биостатические покрытия для замедления и предотвращения бактериальной адгезии
DE60331367D1 (de) Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
DK1162943T3 (da) Ikke-sviende coatingpræparat
ATE205866T1 (de) Hydrophile, hochquellfähige hydrogele
ATE476450T1 (de) Vernetzte polysaccharidzusammensetzung
ATE541587T1 (de) Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen
ATE263579T1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
CO4520232A1 (es) Conjugados de interferon-polimero y proceso para preparar el mismo
DE60210588D1 (de) Plasma oberflächen-pfropfprozess zur thrombogenitäts-reduzierung
CY2603B2 (en) Pharmaceutical compositions
DE60040980D1 (de) Chemisch veränderte, lipolytische enzyme
DE69739085D1 (de) Polymere enthaltend polysaccharide wie alginate oder modifizierte alginate
ATE303407T1 (de) Organometall katalysatorzusammensetzungen
ES2101499T3 (es) Fibras.
KR19980701305A (ko) 1,3,7-옥타트리엔등의 공액 폴리엔으로부터 제조되는 가교결합된 중합체(crosslinked polymers made from 1,3,7-octatriene and like conjugated polyenes)
DE602004019546D1 (de) Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen
ES2066152T3 (es) Composiciones que contienen derivados de la quitina para impedir la adhesion.
EA200300838A1 (ru) Композиция стабилизаторов для галогенированных полимеров, ее применение и полимеры, содержащие такие композиции
BR0005190B1 (pt) processo de preparaÇço de uma composiÇço antimicrobiana.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1183016

Country of ref document: EP

REN Ceased due to non-payment of the annual fee